Alamar Biosciences Shares Climb 33% After Raising $191 Million in U.S. IPO
Shares of Alamar Biosciences Inc. climbed 33% on Friday following the medical device maker's initial public offering that raised $191 million in the United States. The IPO was upsized and priced at the top of a marketed range. @business reported the details of the offering and share performance.
Substrate placeholder — needs reviewAlamar Biosciences Inc. shares climbed 33% on Friday after the company raised $191 million in an initial public offering, @business reported. The initial public offering was upsized and priced at the top of a marketed range.
The initial public offering was conducted in the United States.
Alamar Biosciences Inc. is a medical device maker.
Alamar Biosciences Inc.
Raised $191 million in the initial public offering, which was upsized from its original size.
Transparency
The rewrite presents the IPO facts in a neutral, factual manner without slanted language, speculation, or misdirection.
Reported by a single outlet. This score reflects source tier and factual specificity — corroboration is limited with one source.
Sources framed at 0; our rewrite scored 0 — in line with the sources.
Story details
Related Stories
upi.comNASA Retires MAVEN After 11 Years of Mars Atmosphere Discoveries Following Unrecoverable Anomaly
The agency confirmed Wednesday that the orbiter, launched in 2013, is beyond recovery following a fast spin that drained its batteries. MAVEN completed more than a decade of atmospheric observations at Mars.
foxnews.comTrump Budget Reduces CDC Wastewater Surveillance Funding From $125M to $25M Annually
President Donald Trump's budget plan reduces annual funding for the CDC's National Wastewater Surveillance System from $125 million to $25 million, limiting national coverage after September 30, 2026.